Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bidzinski, Mariusz
NIR-OGT-201, NCT05348356: Nirogacestat in Ovarian Granulosa Cell Tumors	Active, not recruiting	2	53	Europe, Canada, US	Nirogacestat, PF-03084014	SpringWorks Therapeutics, Inc.	Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer	07/26	12/27